
Trulicity Vision Loss Lawsuit: A Complete Update to Everything You Need to Know [2026]
Update on the Trulicity Vision Loss Lawsuit In the Trulicity Vision Loss Lawsuit, federal court judges on the Judicial Panel on Multidistrict Litigation have consolidated lawsuits against Eli Lilly and Novo Nordisk alleging that their GLP-1 Agonists drugs—including Trulicity—cause a rare, permanent eye condition called Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION). In late 2025, the U.S. Judicial Panel on Multidistrict


